Pancreatic cancer (data of the Registry in Novosibirsk, risk factors, prevention options)
Vol. 62 No. 3 (2016), Articles
Vol. 62 No. 3 (2016)

Pancreatic cancer (data of the Registry in Novosibirsk, risk factors, prevention options)

Articles
https://doi.org/10.37469/0507-3758-2016-62-3-433-439
Published 15.12.2016
Research Institute of Therapy and Preventive Medicine
Novosibirsk State Pedagogical University
Research Institute of Therapy and Preventive Medicine
PDF (Русский)

Keywords

morbidity
prevention
pancreatic cancer
Cancer Registry
screening
mortality
risk factors

How to Cite

, , & . (2016). Pancreatic cancer (data of the Registry in Novosibirsk, risk factors, prevention options). Voprosy Onkologii, 62(3), 433–439. https://doi.org/10.37469/0507-3758-2016-62-3-433-439
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

Dynamics of morbidity and mortality from pancreatic cancer in the population of Novosibirsk according to the Population-based Cancer Registry and the Registry of total mortality for 25 years (1988-2012) were analyzed. The morbidity and mortality for the studied period decreased slightly. Incidence rates in middle-aged males are higher than in females but this difference is leveled after 75 years. Possible risk factors for pancreatic cancer as well as issues of screening and prevention are discussed.
https://doi.org/10.37469/0507-3758-2016-62-3-433-439
PDF (Русский)

References

Григорьева И.Н., Ефимова О.В., Суворова Т.С., Тов Н.Л. Панкреатит, рак поджелудочной железы и ожирение: гипотезы и факты // Эксперимент. и клинич. гастроэнтерология. - 2014. - № 9. - С. 4-10.

Злокачественные новообразования в России в 2013 году (заболеваемость и смертность) / Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России, 2015. - 250 с.

Мерабишвили В.М., Мерабишвили Э.Н., Чепик О.Ф. Эпидемиология рака печени. Заболеваемость, смертность, динамика гистологической структуры // Сиб. онкол. журнал. - 2015. - № 2. - С. 5-14.

Никитин Ю.П., Опенко Т.Г., Симонова Г.И. Метаболический синдром и его компоненты как возможные модифицируемые факторы риска рака (литературный обзор) // Сиб. онкол. - 2012. - № 2. - С. 68-72.

Опенко Т.Г., Решетников О.В., Курилович С.А. и др. Колоректальный рак: тенденции за четверть века в Новосибирске, возможности раннего выявления и профилактика // Вопр. онкол. - 2014. - № 6. - С. 687-694.

Пальцев А.И. Клиника, диагностика и лечение хронического описторхоза // Клин. мед. - 2003. - № 4. - С. 49-53.

Состояние онкологической помощи населению России в 2013 году / Под. ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: ФГБУ «МНИОИ им. П.А.Герцена» Минздрава России, 2014. - 235 с.

Bosetti C., Bertuccio P., Negri E. et al. Pancreatic cancer: overview of descriptive epidemiology // Mol Carcinog. - 2012. - Vol. 51. - C. 3-13.

Chang M.C., Wong J.M., Chang Y.T. Screening and early detection of pancreatic cancer in high risk population // World J Gastroenterol. - 2014. - Vol. 20. - P. 2358-2364.

Del Chiaro M., Segersvard R., Lohr M., Verbeke C. Early detection and prevention of pancreatic cancer: Is it really possible today? // World J Gastroenterol. - 2014. - Vol. 20. - P 12118-12131.

Gukovsky I., Li N., Todoric J. et al. Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer // Gastroenterology. - 2013.- Vol. 144.- P. 1199-1209.

Jansen R.J., Tan X.L., Petersen G.M. Gene-by-environment interactions in pancreatic cancer: implications for prevention // Yale J Biol Med. - 2015. - Vol. 88. - P. 115-126.

Klein A.P., Lindstrom S., Mendelsohn J.B. et al. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population // PLoS One. - 2013. - Vol. 8. - P. e72311.

Li D., Yeung S.-C.J., Hassan M.M. et al. Antidiabetic therapies affect risk of pancreatic cancer // Gastroenterology. - 2009. - Vol. 137. - P. 482-488.

Munigala S., Kanwal F., Xian H., Agarwal B. New diagnosis of chronic pancreatitis: risk of missing an underlying pancreatic cancer // Am J Gastroenterol.- 2014. - Vol. 109. - 1824-1830.

Neureiter D., Jager T, Ocker M, Kiesslich T. Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects // World J Gastroenterol. - 2014. - Vol. 20. - P. 7830-7848.

Poruk K.E., Firpo M.A., Adler D.G., Mulvihill S.J. Screening for pancreatic cancer: why, how, and who? // Ann Surg.- 2013. - Vol. 257. - P. 17-26.

Wolfgang C.L., Herman J.M., Laheru D.A. et al. Recent progress in pancreatic cancer // CA Cancer J Clin.- 2013. - Vol. 63. - P. 318-348.

World Health Organization. World Health Organization Statistical Information System. WHO Mortality Database, 2012. Available from:http://www3.who. int/whosis/menu. cfm.

Wormann S.M., Algul H. Risk factors and therapeutic targets in pancreatic cancer // Front Oncol. - 2013. - Vol. 3. - Article 282. - P 1-17.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...